Please login to the form below

I have forgotten my password

ICS

This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

AZ’s COPD triple data sets up market clash with GSK

on LABA vilanterol, LAMA umeclidinium and ICS fluticasone furoate - in the US and Europe last year.

Latest news

EMA approves GSK’s triple COPD therapy

moderate to severe COPD who are not adequately treated by the combination of an inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA). ... The same indication was approved by the FDA in September, and makes Trelegy the first drug on the
With US approval, GSK now needs rapid uptake for COPD triple

The three-drug product delivers a long-acting beta agonist (LABA), a long-acting muscarinic antagonist (LAMA) and an inhaled corticosteroid (ICS) from a single device, and is the first product
GSK closes in on EU approval for triple COPD therapy

The new product adds long-acting muscarinic receptor antagonist (LAMA) umeclidinium to the ICS/LABA combination, which has proved so successful in GSK's big-selling Advair/Seretide (fluticasone propionate/salmeterol) ... The benefits of Trelegy/Elebrato -
GSK preps COPD filing for asthma pioneer Nucala

Aside from Nucala, GSK is pinning its near-term hopes on dolutegravir-based HIV therapies and its closed triple therapy for COPD – delivering inhaled corticosteroid (ICS) fluticasone furoate, long-acting beta
Chiesi Group's Trimbow wins European licence

The treatment comprises an inhaled corticosteroid (ICS), long-acting beta2-agonist (LABA) and long-acting muscarinic antagonist (LAMA) in one inhaler and is the such triple combination COPD therapy to be ... Administered twice daily at a fixed dose,

More from news
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest Intelligence

Deal Watch table for August 2014

600. TARIS Biomedical/ Allergan. Company acquisition. LiRIS for interstitial cystitis / bladder pain syndrome (IC/BPS) (phase II).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Raising Awareness: It’s World COPD Day today!

Inhaled corticosteroids (ICS) are another COPD treatment used to reduce inflammation in the lungs. ... Interestingly, no advantage in adding ICS to bronchodilator therapy in patients at low risk of exacerbations has been observed.
Managing local population needs is key for the NHS

year. These plans should “ align key assumptions on income, expenditure, activity and workforce” and system leaders within the ICS are expected to take an “ active role in this process”. ... efficiencies. Conclusion. STPs and the newly emerging
How can pharma engage with key decision-makers in new, collaborative NHS care models?

This has resulted in an increasingly complex, multi-layered healthcare system that is seeing some GPs taking on wide-ranging responsibilities in Integrated Care System (ICS) areas. ... work in an alliance within the ICS.
Large-scale NHS commissioning models require new partnership approach from pharma

Some of the mergers have been entered into voluntarily to help cut costs and ultimately pave the way for the introduction of Accountable or Integrated Care System (ACS/ICS) models; while
IC Consultants Ltd

IC Consultants Ltd. We are the UK’ s leading academic consultancy provider, connecting external organisations to the knowledge and resources of Imperial College London. ... IC Consultants Ltd.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Home based, Principal Medical Writer, Medical Communications: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Multi-Channel Account Managers - Road / Homebased – Full or Part...: Competitive salary

Account Manager: £40, 000 - £45, 000 benefits

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Editorial Director – Medical Education (MedComms): Neg

Home based, Chief Medical Writer, Medical Communications: Excellent package

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Senior Account Manager: Competitive salary commensurate with experience

Business Unit Head, Medical Communications, London: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Client Services Director - Med Comms: Great salary and bebefits

Senior Project Manager - Medical Writing: Great salary and bebefits

Delivery Manager/ Head of Delivery – Executive Search: Neg

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Client Services Director – Healthcare Advertising - London: Neg

Subscribe to our email news alerts

PMHub

Add my company

Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape: Is it a solution to addressing the challenges of the value-based marketplace?...
Creativity has lost its worth: Creativity has lost its worth, and sadly it is undermining effectiveness...